IP Library › Assignment 056023/0766
Patent Assignment
Reel/Frame 056023/0766

Assignment of Assignor's Interest

Recorded: 2021-04-23 Pages: 3
Assignor
LIU, CHENG
Executed: 2016-08-17
Assignee
EUREKA THERAPEUTICS, INC.
5858 HORTON STREET, SUITE 362, EMERYVILLE, CALIFORNIA, 94608
Covered Properties (3)
Methods of Treating Cancers Using Anti-GPRC5D Antibodies
Application: 16/731,973 →
Publication: US 2020/0123249
Antibodies Targeting G-Protein Coupled Receptor and Methods of Use
Application: 15/614,290 →
Publication: US 2018/0118822
Nucleic Acid Molecules Encoding Anti-GPRC5D Antibodies
Application: 16/732,022 →
Publication: US 2020/0123250
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger Apr 2, 2018
From: EUREKA THERAPEUTICS, INC.
To: EUREKA THERAPEUTICS, INC.
Reel/Frame 045407/0783 →
Confirmatory Patent Assignment Apr 23, 2021
From: BRENTJENS, RENIER J.; SMITH, ERIC L.
To: MEMORIAL SLOAN-KETTERING CANCER CENTER
Reel/Frame 056032/0050 →
Assignment of Assignor's Interest Apr 13, 2026
From: LIU, HONG
To: EUREKA THERAPEUTICS, INC.
Reel/Frame 074353/0676 →
Assignment of Assignor's Interest Apr 21, 2026
From: LIU, HONG
To: EUREKA THERAPEUTICS, INC.
Reel/Frame 074428/0378 →
Merger Aug 18, 2026
From: EUREKA THERAPEUTICS, INC., A CALIFORNIA CORPORATION
To: EUREKA THERAPEUTICS, INC., A DELAWARE CORPORATION
Reel/Frame 075688/0345 →